The global ambulatory polysomnography systems market is envisioned to garner $570.7 million by 2031, growing from $327.0 million in 2021 at a CAGR of 6.0% from 2022 to 2031.
Ambulatory polysomnography (Amb-PSG), also known as type II PSG, can be used to identify different sleep disorders by characterizing sleep stages and quantifying arousals, total sleep time (TST), and an accurate respiratory disturbance index (RDI). Ambulatory polysomnography systems are in high demand among patients suffering from a variety of sleep disorders due to the benefits they provide. This is propelling the ambulatory polysomnography systems market.
The majority of the population, particularly in rural regions, is uninformed of the dangers of sleep apnea. Sleep disorders that go untreated can lead to chronic ailments like heart failure, stroke, high blood pressure, diabetes, and obesity. This can result in major health issues such as uncontrolled blood pressure, heart attacks, weakened and restricted blood vessels in the kidneys, and aneurysms. The population's lack of awareness about sleeping difficulties is expected to stymie the growth of the ambulatory polysomnography systems market in the near future.
Technological improvements in the sleep care business can be identified as a driving force in this market. The ambulatory polysomnography systems market is growing steadily due to numerous revolutionary technologies such as portable devices, smartphone applications, telemedicine, and so on. Wireless and portable polysomnography systems, like as Nox Medical's Nox A1s PSG, have benefited from research and development. Wireless capabilities give patients with a sense of liberty by allowing them freedom of movement while they are being diagnosed. This will have a beneficial impact on the growth of the ambulatory polysomnography systems market.
The global market has benefited by the outbreak of the COVID-19 pandemic. Key participants claimed considerable revenue growth as a result of an Increase in the number of patients suffering from sleep difficulties as a result of the COVID19 pandemic. According to the poll, 70% of respondents have experienced one or more new sleep issues Ince the start of the COVID-19, leading to an Increase in the use of sleep apnea equipment. As a result of this, the PSG systems’ businesses launched a clinically certified, low-touch CPAP Mask Selector tool that can be utilized remotely from the patient's home.
The key players profiled in this report Include Koninklijke Philips N.V., Natus Medical Incorporated, Nihon Kohden Corporation, Nox Medical, Löwenstein Medical Technology GmbH + Co. KG., neurosoft, Cadwell Industries Inc., SOMNOmedics GmbH, Compumedics Limited, and Neurovirtual / Sleepvirtual.
Ambulatory polysomnography (Amb-PSG), also known as type II PSG, can be used to identify different sleep disorders by characterizing sleep stages and quantifying arousals, total sleep time (TST), and an accurate respiratory disturbance index (RDI). Ambulatory polysomnography systems are in high demand among patients suffering from a variety of sleep disorders due to the benefits they provide. This is propelling the ambulatory polysomnography systems market.
The majority of the population, particularly in rural regions, is uninformed of the dangers of sleep apnea. Sleep disorders that go untreated can lead to chronic ailments like heart failure, stroke, high blood pressure, diabetes, and obesity. This can result in major health issues such as uncontrolled blood pressure, heart attacks, weakened and restricted blood vessels in the kidneys, and aneurysms. The population's lack of awareness about sleeping difficulties is expected to stymie the growth of the ambulatory polysomnography systems market in the near future.
Technological improvements in the sleep care business can be identified as a driving force in this market. The ambulatory polysomnography systems market is growing steadily due to numerous revolutionary technologies such as portable devices, smartphone applications, telemedicine, and so on. Wireless and portable polysomnography systems, like as Nox Medical's Nox A1s PSG, have benefited from research and development. Wireless capabilities give patients with a sense of liberty by allowing them freedom of movement while they are being diagnosed. This will have a beneficial impact on the growth of the ambulatory polysomnography systems market.
The global market has benefited by the outbreak of the COVID-19 pandemic. Key participants claimed considerable revenue growth as a result of an Increase in the number of patients suffering from sleep difficulties as a result of the COVID19 pandemic. According to the poll, 70% of respondents have experienced one or more new sleep issues Ince the start of the COVID-19, leading to an Increase in the use of sleep apnea equipment. As a result of this, the PSG systems’ businesses launched a clinically certified, low-touch CPAP Mask Selector tool that can be utilized remotely from the patient's home.
The key players profiled in this report Include Koninklijke Philips N.V., Natus Medical Incorporated, Nihon Kohden Corporation, Nox Medical, Löwenstein Medical Technology GmbH + Co. KG., neurosoft, Cadwell Industries Inc., SOMNOmedics GmbH, Compumedics Limited, and Neurovirtual / Sleepvirtual.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the ambulatory polysomnography (psg) systems market analysis from 2021 to 2031 to identify the prevailing ambulatory polysomnography (psg) systems market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the ambulatory polysomnography (psg) systems market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report Includes the analysis of the regional as well as global ambulatory polysomnography (psg) systems market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Product
- Up to 12 Channel PSG Systems
- Up to 24 Channel PSG Systems
- Up to 32 Channel PSG Systems
- Above 32 Channel PSG Systems
By Application
- Obstructive Sleep
- Apnea Narcolepsy
- Chronic Insomnia
- Others
By End-User
- Hospitals
- Sleep Laboratories
- Home Care Settings
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia-Pacific
- LAMEA
- Brazil
- United Arab Emirates
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- Cadwell Industries Inc.
- Compumedics Limited
- Compumedics Limited
- Koninklijke Philips N.V.
- Löwenstein Medical Technology GmbH + Co. KG.
- Natus Medical Incorporated
- neurosoft
- Nihon Kohden Corporation
- Nox Medical
- SOMNOmedics GmbH
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT
CHAPTER 5: AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION
CHAPTER 6: AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER
CHAPTER 7: AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY REGION
CHAPTER 8: COMPETITIVE LANDSCAPE
CHAPTER 9: COMPANY PROFILES
List of Tables
List of Figures
Executive Summary
According to a new report, titled, 'Ambulatory Polysomnography (Psg) Systems Market,' The ambulatory polysomnography (psg) systems market was valued at $327.00 million in 2021, and is estimated to reach $570.7 million by 2031, growing at a CAGR of 6% from 2022 to 2031.Portable equipment called ambulatory polysomnography systems is used to diagnose and evaluate sleep problems. These devices are made to be worn by patients as they snooze in their own beds, enabling more precise data collecting and a more natural sleep environment. EEG, EOG, EMG, ECG, respiratory effort and airflow, heart rate, breathing patterns, oxygen levels, and pulse oximetry are just a few of the physiological processes that are typically monitored by ambulatory PSG systems when a person is sleeping. To identify sleep disorders such sleep apnea, narcolepsy, and restless leg syndrome, sleep specialists often analyze the data gathered by ambulatory PSG devices. These devices are especially helpful for patients who have trouble falling asleep in a lab setting because they enable more cosy and natural sleeping settings. Patients can utilize ambulatory PSG devices to track changes in their sleep patterns and symptoms, which makes them ideal for tracking treatment success over time.
The large undiagnosed sleep apnea population is a major factor encouraging the development and uptake of ambulatory equipment. According to estimates, a significant number of persons suffering from sleep apnea goes untreated, preventing them from receiving the essential care to control their disease. This is typically caused by the difficulty and discomfort of having a standard PSG performed in a laboratory setting, as well as a lack of access to sleep laboratories. Ambulatory PSG technology provides a more practical and accessible way for diagnosing sleep apnea and other sleep disorders. Patients may be more inclined to seek a diagnosis and treatment if they may use these devices in the comfort of their own homes. Additionally, compared to conventional home sleep apnea tests (HSATs), ambulatory PSG systems can give sleep specialists more precise data, which can result in more accurate diagnoses and improved treatment outcomes. All things considered, ambulatory PSG devices offer the potential to increase access to sleep disorder diagnosis and treatment, especially for people who are now undiagnosed or unable to access conventional sleep laboratory services.
The market is expected to have a confident outlook due to the rising application of artificial intelligence in PSG systems. Ambulatory PSG sleep studies are becoming a useful diagnostic tool for sleep disorders. Ambulatory PSG facilitates the performance of an overnight polysomnography examination that addresses the patient's comfort in his or her home. It gathers each and every piece of information required for a complete sleep diagnostic investigation. By transferring sleep studies from the laboratory to the house, these devices give sleep clinics the flexibility of wireless and portable PSG systems, allowing them to treat more patients. Artificial intelligence is being used in the field of sleep diagnostics by manufacturers as a response to the trend towards home sleep examinations. This could be viewed as an opportunity for the market for ambulatory polysomnography technologies to expand.
The ambulatory polysomnography systems market has substantial development potential because of the vast undiagnosed population with respect to sleep apnea. According to one of the National Centre for Biotechnology Information's study publications, sleep apnea is a very common illness in the United States that often remains untreated. Because of the advantages afforded by this system over in-lab polysomnography systems, this aspect is expected to boost the market for ambulatory polysomnography (PSG) systems.
The ambulatory polysomnography (PSG) systems market is segmented on the basis of product, application, end-user, and region. On the basis of product, the market is classified into Up to 12 channel PSG systems, Up to 24 channel PSG systems, Up to 32 channel PSG systems, and above 32 channel PSG systems. On the basis of application, the market is classified into obstructive sleep apnea, narcolepsy, chronic insomnia and others. On the basis of end-user, the market is classified into hospitals, sleep laboratories, and home care settings. On the basis of region, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (UK, Germany, France, Italy, Spain, and rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Australia, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, United Arab Emirates, South Africa, and rest of LAMEA).
The key players profiled in the study include Koninklijke Philips N.V., Natus Medical Incorporated, Nihon Kohden Corporation, Nox Medical, Löwenstein Medical Technology GmbH + Co. KG., neurosoft, Cadwell Industries Inc., SOMNOmedics GmbH, Compumedics Limited, and Neurovirtual / Sleepvirtual.
Key Market Insights
- Based on product, the up to 24 channel PSG systems sub-segment emerged as the global leader in 2021 and is anticipated to be the fastest growing sub-segment during the forecast period.
- Based on application, the obstructive sleep apnea sub-segment emerged as the global leader in 2021 and chronic insomnia sub-segment is anticipated to be the fastest growing sub-segment during the forecast period.
- Based on end-user, the sleep laboratories sub-segment emerged as the global leader in 2021 and is anticipated to be the fastest growing sub-segment during the forecast period.
- Based on region, the North America market registered the highest market share in 2021 and is projected to maintain its position during the forecast period.
Companies Mentioned
- Cadwell Industries Inc.
- Compumedics Limited
- Compumedics Limited
- Koninklijke Philips N.V.
- Löwenstein Medical Technology GmbH + Co. KG.
- Natus Medical Incorporated
- neurosoft
- Nihon Kohden Corporation
- Nox Medical
- SOMNOmedics GmbH
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
